FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

White Paper on Improving Accelerated Approval Path

An Institute for Clinical and Economic Review white paper states the potential benefits and challenges of several policy changes that could strengthen...

Medical Devices

AdvaMed Recommendations for Class 2 Notification Exemption

AdvaMed says it supports FDA efforts to expand exemptions from premarket notification for some Class 2 devices.

FDA General

Trump Names Erica Schwartz to Head CDC

The Trump administration nominates former deputy surgeon general Erica Schwartz to be CDC director, and taps FDA principal deputy commissioner Sara Br...

latest-news-card-1
Animal Drugs

Lilly to Seek FDA Approval for Foundayo in Diabetes

Eli Lilly says it will seek expanded FDA approval by the end of the quarter for its obesity drug Foundayo (orforglipron) as a treatment for diabetes, ...

Human Drugs

FDA Satellite Labs Block Illegal Drugs: Batson

FDA satellite laboratories branch director JaCinta Batson touts the value of the laboratories work in international mail facilities to stop illegal an...

Animal Drugs

2 CDER Postmarketing MAPPS Out

CDER issues two revised Manuals of Policies and Procedures relating to developing and communicating postmarketing requirements and commitments.

latest-news-card-1
Human Drugs

FDA Panel Meeting to Mull Adding Peptides to Compounding List

FDA plans a 7/23-24 Pharmacy Compounding Advisory Committee meeting to discuss adding certain peptides to the agencys bulk drugs for compounding list....

latest-news-card-1
Medical Devices

Town Hall Discusses QMSR Basics and Answers Questions

An FDA town hall gives a detailed explanation of the new medical device Quality Management System Regulation and answers frequently asked questions ab...

latest-news-card-1
Human Drugs

Change Labeling for Hormonally Active Contraceptives: Petition

The Contraceptive Study Group submits a second petition to FDA seeking changes in labeling for hormonally active contraceptives to reflect all of the ...

latest-news-card-1
Human Drugs

FDA Extends Molgramostim BLA Review for 3 Months

FDA extends until 11/22 its review of a Savara BLA for molgramostim to treat autoimmune pulmonary alveolar proteinosis.